The $10 million doesn't just get wiped off the books. Any accountant or financial person knows that it gets moved to a different Account, albiet with other details involved. After the R/S, with the conversions that will take place, Shareholders will be diluted even worse. After the conversions, Shareholders may be lucky to have the stock not drop in value to the .0001 level again and may end up with anywhere from 5 to 20% of their pre-converted value. For example, lets say a shareholder has 10 million shares, at .0001, that is $1,000. After the R/S, they have 1 million shares at .001, or still $1,000. But because it is known that the stock is going to be diluted (PWC has already stated that debt will be converted into equity), then the PPS will immediately fall. And when the dilution does occur, the Market Makers will revalue the PPS downwards as well, so in the end, you may still have a million shares, but the PPS may be only .0002, or your $1,000 is now worth only $200. So, "Um, let's see:" , shareholders and new investors are still losing a good part of what they had or just bought.
Now the acclaimed "medical device". There is no audited appraisal that I have seen, yet, that this device is worth any 30 million, and without that audited appraisal, the 30 million is just speculation.
So again, I warn, shareholders and investors should require that PWC provide full disclosure on their relationships and the indebtedness of NIR to PWC, and what their plans are for the sale of the equity that the debt is being converted into.
AI
Market Data 
Markets 
